As announced on 18 March 2024, the Company offered a partial buy-back to the holders of the Company's outstanding senior secured floating rate bonds maturing on 26 May 2026 with ISIN SE0020180271 (the "SEK Bonds") in connection with the Bond Issue (the "Buy-Back"). SEK Bonds in an aggregate nominal amount of SEK 400 million were repurchased by the Company in the Buy-Back at a price equal to 104.25 per cent of the nominal amount plus accrued and unpaid interest from, but excluding, the previous interest payment date until, and including, the settlement date of the Buy-Back. Settlement of the Buy-Back will coincide with the settlement of the Bond Issue which is expected to take place on 4 April 2024.

The Bond Issue and the Buy-Back mark an important milestone for ADDvise in aligning its long-term funding with its operational currency exposure and at the same time extending the Company's debt maturity profile.

Pareto Securities AB acted as Sole Global Coordinator and Joint Bookrunner and Skandinaviska Enskilda Banken AB (publ) acted as Joint Bookrunner in connection with the transaction. Gernandt & Danielsson Advokatbyrå acted as legal advisor.

For further information, please contact:
Rikard Akhtarzand, CEO
+46(0)76-525 90 71
rikard.akhtarzand@addvisegroup.se

Oliver Humlen, CFO
+46 (0)70-916 26 97
oliver.humlen@addvisegroup.se

About ADDvise Group AB (publ)

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.